Binding of the brain G protein G⍺o to its potential effector RASA3 is promoted by Ca2+

G⍺<sub>o</sub>, the alpha subunit of the most abundant heterotrimeric G protein in the brain, mediates signaling by opioids and by many neuromodulators to inhibit neural function. An open question is whether activated G⍺<sub>o</sub>-GTP directly binds to and regulates effector molecules, like all other animal G⍺ proteins, or if it signals solely by releasing Gβγ subunits. Using mouse brain lysates as native source of G⍺<sub>o</sub> and its potential effectors, we analyzed immunopurified G⍺<sub>o</sub> protein complexes by mass spectrometry. Pre-activating G⍺<sub>o</sub> in the lysates with GTPγS resulted in a ∼6-fold increase in the amount of the small G protein GTPase activators RASA3 and RASA2 in the purified complexes, the largest increase among all G⍺<sub>o</sub>-associated proteins, making RASA2/3 candidate G⍺<sub>o</sub> effectors. Using purified recombinant proteins, we found that RASA3 binds directly to G⍺<sub>o</sub>-GTPγS more strongly than it does to G⍺<sub>o</sub>-GDP. We also found that the addition of Ca<sup>2+</sup>, a second messenger produced by the G⍺<sub>q</sub> pathway that opposes G⍺<sub>o</sub> signaling, strengthened binding of RASA3 to G⍺<sub>o</sub>-GDP. A C-terminal fragment of RASA3 containing a predicted Ca<sup>2+</sup> site was sufficient to bind G⍺<sub>o</sub>, albeit more weakly and without a preference for the activated state of G⍺<sub>o</sub>. We present a model in which RASA3 could mediate G⍺<sub>o</sub> signaling using two distinct G⍺<sub>o</sub>-binding sites: one on full-length RASA3 that preferentially binds active G⍺<sub>o</sub>-GTP and a second on the RASA3 C terminus that binds inactive G⍺<sub>o</sub> in the presence of Ca<sup>2+</sup>.

Authors

Institutions

Publication Details

Journal
Journal of Biological Chemistry
Published
2025-12-03
DOI
https://doi.org/10.1016/j.jbc.2025.110999
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Binding of the brain G protein G⍺o to its potential effector RASA3 is promoted by Ca2+

TuKiet T. Lam, Andrew Olson, Michael R. Koelle, Juliana E Gentile et al.
Journal of Biological Chemistry
Neuroscience and Neuropharmacology Research
article

Binding of the brain G protein G⍺o to its potential effector RASA3 is promoted by Ca2+

TuKiet T. Lam, Andrew Olson, Michael R. Koelle, Juliana E Gentile, H. Bell
article en

Abstract

G⍺<sub>o</sub>, the alpha subunit of the most abundant heterotrimeric G protein in the brain, mediates signaling by opioids and by many neuromodulators to inhibit neural function. An open question is whether activated G⍺<sub>o</sub>-GTP directly binds to and regulates effector molecules, like all other animal G⍺ proteins, or if it signals solely by releasing Gβγ subunits. Using mouse brain lysates as native source of G⍺<sub>o</sub> and its potential effectors, we analyzed immunopurified G⍺<sub>o</sub> protein complexes by mass spectrometry. Pre-activating G⍺<sub>o</sub> in the lysates with GTPγS resulted in a ∼6-fold increase in the amount of the small G protein GTPase activators RASA3 and RASA2 in the purified complexes, the largest increase among all G⍺<sub>o</sub>-associated proteins, making RASA2/3 candidate G⍺<sub>o</sub> effectors. Using purified recombinant proteins, we found that RASA3 binds directly to G⍺<sub>o</sub>-GTPγS more strongly than it does to G⍺<sub>o</sub>-GDP. We also found that the addition of Ca<sup>2+</sup>, a second messenger produced by the G⍺<sub>q</sub> pathway that opposes G⍺<sub>o</sub> signaling, strengthened binding of RASA3 to G⍺<sub>o</sub>-GDP. A C-terminal fragment of RASA3 containing a predicted Ca<sup>2+</sup> site was sufficient to bind G⍺<sub>o</sub>, albeit more weakly and without a preference for the activated state of G⍺<sub>o</sub>. We present a model in which RASA3 could mediate G⍺<sub>o</sub> signaling using two distinct G⍺<sub>o</sub>-binding sites: one on full-length RASA3 that preferentially binds active G⍺<sub>o</sub>-GTP and a second on the RASA3 C terminus that binds inactive G⍺<sub>o</sub> in the presence of Ca<sup>2+</sup>.

Journal of Biological ChemistryVol. 302(1)
Yale University (US)
Yale University, National Institutes of Health, National Institute on Drug Abuse
Openalex Percentile: Top 59%
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.